Chinese maker of digital X-ray flat-panel detectors used in medical imaging, dental, veterinary and industrial inspection.
Chinese maker of digital X-ray flat-panel detectors used in medical imaging, dental, veterinary and industrial inspection.
Makes the flat-panel detector inside an X-ray machine and sells it to imaging-equipment makers, who design it into their products, so a qualified model is bought repeatedly over the machine's life. Dental, veterinary and industrial inspection uses broaden the base beyond hospital radiology.
In one line: A Chinese Varex Imaging (X-ray detector maker).
Moat: narrow (IP / patents, process know-how). Detector manufacturing know-how and OEM qualification are not easily replicated.
Headquarters: Shanghai, China · Employees: 2,292
Size iRay Technology (688301.SS) is a China Health Care company (Medical Specialties) with a market value of $3.31B, the 733rd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥70.72 on 18 Nov 2026.
Performance Over six months the shares fell 29.9%, against +11.1% for the median peer and -20.0% for the China market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 58.5% over the last twelve months (peer median +5.7%); the operating margin is 23.9% (peer median 7.3%).
Valuation It trades at 25.7× forward earnings against a peer median of 26.6× (10th cheapest of 19).
Capital Return on invested capital runs 1.2 points below its cost of capital (10.3% WACC).
Next results Next results expected around 12 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥3.20B | CN¥2.24B | CN¥1.83B | CN¥1.86B | CN¥1.54B |
| Revenue growth | — | +23% | -2% | +21% | — |
| Gross profit | CN¥1.77B | CN¥1.10B | CN¥888M | CN¥1.03B | CN¥861M |
| EBITDA | n/a | CN¥787M | CN¥488M | CN¥676M | CN¥532M |
| Net income | CN¥752M | CN¥650M | CN¥465M | CN¥607M | CN¥641M |
| Free cash flow | -CN¥762M | -CN¥384M | -CN¥1.08B | -CN¥1.51B | -CN¥400M |
| Capital expenditure | CN¥1.61B | CN¥1.69B | CN¥1.44B | CN¥1.85B | CN¥717M |
| Total debt | CN¥3.26B | CN¥4.32B | CN¥3.60B | CN¥2.14B | CN¥1.48B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| iRay Technology 688301.SS | $3.31B | -30% | +58% | 24% | 25.7× | n/a |
| Varex Imaging VREX | $771M | +79% | +5% | 8% | 19.9× | n/a |
| Teledyne Technologies TDY | $28.9B | +2% | +8% | 20% | 23.2× | 16.2% |
| Hamamatsu Photonics K.K 6965.T | $3.91B | -24% | +15% | 11% | 28.1× | 17.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688301.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.0% | +3.0% | 7th lowest of 21 |
| 6-month return | -29.9% | +11.1% | lowest of 21 |
| Distance from 52-week high | -53.9% | -22.1% | lowest of 21 |
| Revenue growth (TTM) | +58.5% | +5.7% | 2nd highest of 21 |
| Operating margin | 23.9% | 7.3% | 2nd highest of 20 |
| Forward P/E | 25.7× | 26.6× | 10th cheapest of 19 |
| ROIC minus cost of capital | -1.2 pp | -1.6 pp | 10th highest of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| iRay Technology 688301.SS | China | $3.31B | -30% | +58% | 24% | 25.7× | n/a | n/a |
| TransMedics TMDX | United States | $3.35B | +42% | +28% | 12% | 43.4× | 38.4% | +88.2% |
| Autobio Diagnostics 603658.SS | China | $3.36B | +16% | +3% | 25% | 20.3× | -0.4% | +7.2% |
| Zhende Medical 603301.SS | China | $3.26B | -10% | +8% | 7% | 42.5× | 22.9% | -16.1% |
| Pulse Biosciences PLSE | United States | $3.37B | +76% | +1,637% | -5,821% | n/a | n/a | n/a |
| Axogen AXGN | United States | $3.40B | +33% | +24% | -5% | 87.3× | 52.6% | +14.9% |
| Lepu Medical Technology (Beijing) 300003.SZ | China | $3.20B | -13% | -1% | 13% | 24.4× | 8.7% | -4.2% |
| iRhythm IRTC | United States | $3.19B | -19% | +22% | 5% | 99.8× | 46.9% | +23.0% |
| Carl Zeiss Meditec AFX.DE | Germany | $3.17B | +22% | 0% | 8% | 24.4× | 12.5% | +10.8% |
| Ambu A/S AMBU-B.CO | Denmark | $3.47B | +31% | +7% | 13% | 28.8× | 10.0% | +10.0% |
| Sumitomo Bakelite 4203.T | Japan | $3.50B | +7% | +15% | 13% | 15.9× | 8.6% | +8.9% |
| MGI Tech 688114.SS | China | $3.06B | -4% | +2% | -7% | n/a | 43.7% | -0.1% |
| Tecan TECN.SW | Switzerland | $3.60B | +59% | -4% | 1% | 35.5× | 45.4% | +3.8% |
| Shandong Weigao Blood Purification Products 603014.SS | China | $3.63B | -1% | +4% | n/a | 20.4× | -1.2% | +8.1% |
| SCHOTT Pharma AG & Co. KGaA 1SXP.DE | Germany | $3.73B | +32% | +4% | 15% | 23.0× | 12.7% | +11.0% |
| Envista NVST | United States | $3.81B | 0% | +10% | 12% | 14.7× | 4.8% | +7.1% |
| Andon Health 002432.SZ | China | $3.86B | -24% | -30% | -26% | 16.1× | -6.6% | -7.4% |
| AtriCure ATRC | United States | $2.82B | +91% | +14% | 3% | 212.4× | 54.2% | +20.9% |
| CareDx CDNA | United States | $3.91B | +252% | +39% | 1% | 50.6× | n/a | n/a |
| Fielmann FIE.DE | Germany | $3.92B | -3% | +3% | 14% | 17.1× | -5.5% | +11.3% |
| COMET COTN.SW | Switzerland | $2.78B | -15% | -3% | 6% | 32.8× | n/a | n/a |